Can you stop a GLP-1 cold turkey?

For most people using it for weight, no. GLP-1 medications do not cause a withdrawal syndrome the way benzodiazepines or antidepressants can; the drug simply clears along its half-life and your own appetite signaling resumes. The important exception is anyone taking it for type 2 diabetes or blood sugar control: stopping abruptly means losing that control, and that conversation with your prescriber should happen before the last dose, not after.

Physically, yes; there is no taper mandated by the label and no withdrawal syndrome. Tirzepatide has a roughly 5-day half-life, so the first week feels normal, appetite returns over weeks 2 to 4, and the drug is essentially gone within about a month. The real question is not whether you can, it is whether your protein floor, strength habit and weigh-in trend are in place before hunger arrives, because in SURMOUNT-4 the average person who stopped without structure regained most of their loss within a year.

Same answer with slower math: semaglutide has a roughly 7-day half-life, so the transition stretches about a week longer than tirzepatide. Nothing dramatic happens in week one, appetite returns in earnest over weeks 2 to 5, and full clearance takes about 5 weeks. The STEP trials show the same average-regain pattern after withdrawal, which is a statement about missing structure more than about you.

Not in the pharmacological sense. What people describe, returning hunger, food noise switching back on, energy dips, a fast few pounds on the scale, is the underlying appetite system resuming plus water and glycogen restocking, not withdrawal. The scale jump in particular is overwhelmingly water in the first two weeks. Knowing the difference matters, because misreading normal biology as withdrawal or instant regain is what sends people into panic decisions in week three.

No randomized trial has settled it, so anyone speaking in certainties is past the evidence. What is mechanically true: tapering lowers your drug level in steps, so the appetite transition arrives in installments over months, while cold turkey delivers it in one 3-to-6-week window. Many clinicians favor stepping down for exactly that reason, and many people are forced cold turkey by insurance or supply anyway. Either way, dose decisions belong with your prescriber, and the structure you bring matters more than the exit style.

They fade on the same clearance curve either way: as levels fall over the first one to two weeks, GI side effects typically ease, and being fully clear takes about a month for tirzepatide and about five weeks for semaglutide. If intolerable side effects are the reason you are stopping, that is precisely the situation to loop in your prescriber, since a dose adjustment sometimes solves what a full stop is being asked to solve.

Use week one, which feels deceptively normal, to set structure: a protein floor near 1.6 g per kg of goal weight, two strength sessions on the calendar, fiber at 25 to 30 grams, and a weekly weigh-in average with a line you have chosen in advance. Weeks 2 through 6 are when appetite returns and can briefly overshoot. Hunger showing up is the expected event, not the emergency; meeting it with a plan is the whole game.